Interaction of 2A proteinase of human rhinovirus genetic group A with eIF4E is required for eIF4G cleavage during infection

Virology

Volumn 511, Issue , 2017, Pages 123-134

  Aumayr, Martina ^a   Schrempf, Anna ^a   Üzülmez, Öykü ^a   Olek, Karin M ^a   Skern, Tim ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cap binding protein; Chymotrypsin like cysteine proteinase; Host cell shut off; Initiation of protein synthesis; Protein protein interactions; Virus host interactions

Indexed keywords

CYSTEINE PROTEINASE; EIF4G1 PROTEIN, HUMAN; INITIATION FACTOR 4E; INITIATION FACTOR 4G; PICORNAIN 2A, PICORNAVIRUS; PROTEIN BINDING; VIRAL PROTEIN;

DNA MUTATIONAL ANALYSIS; ENZYMOLOGY; GENETICS; GENOTYPE; HOST PATHOGEN INTERACTION; HUMAN; HYDROLYSIS; METABOLISM; MOLECULAR MODEL; PATHOGENICITY; PROTEIN ANALYSIS; RHINOVIRUS;

CYSTEINE ENDOPEPTIDASES; DNA MUTATIONAL ANALYSIS; EUKARYOTIC INITIATION FACTOR-4E; EUKARYOTIC INITIATION FACTOR-4G; GENOTYPE; HOST-PATHOGEN INTERACTIONS; HUMANS; HYDROLYSIS; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; RHINOVIRUS; VIRAL PROTEINS;

EID: 85028005137     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2017.08.020     Document Type: Article

References (48)

1. Aumayr, M., Fedosyuk, S., Ruzicska, K., Sousa-Blin, C., Kontaxis, G., Skern, T., NMR analysis of the interaction of picornaviral proteinases Lb and 2A with their substrate eukaryotic initiation factor 4GII. Protein Sci.: Publ. Protein Soc. 24 (2015), 1979–1996.
2. Baxter, N.J., Roetzer, A., Liebig, H.D., Sedelnikova, S.E., Hounslow, A.M., Skern, T., Waltho, J.P., Structure and dynamics of coxsackievirus B4 2A proteinase, an enzyme involved in the etiology of heart disease. J. Virol. 80 (2006), 1451–1462.
3. Bovee, M.L., Marissen, W.E., Zamora, M., Lloyd, R.E., The predominant elF4G-specific cleavage activity in poliovirus-infected HeLa cells is distinct from 2A protease. Virology 245 (1998), 229–240.
4. Cai, Q., Yameen, M., Liu, W., Gao, Z., Li, Y., Peng, X., Cai, Y., Wu, C., Zheng, Q., Li, J., Lin, T., Conformational plasticity of the 2A proteinase from enterovirus 71. J. Virol. 87 (2013), 7348–7356.
5. Cencic, R., Mayer, C., Juliano, M.A., Juliano, L., Konrat, R., Kontaxis, G., Skern, T., Investigating the substrate specificity and oligomerisation of the leader protease of foot and mouth disease virus using NMR. J. Mol. Biol. 373 (2007), 1071–1087.
6. Chase, A.J., Semler, B.L., Viral subversion of host functions for picornavirus translation and RNA replication. Future Virol. 7 (2012), 179–191.
7. Comeau, S.R., Gatchell, D.W., Vajda, S., Camacho, C.J., ClusPro: a fully automated algorithm for protein-protein docking. Nucleic Acids Res. 32 (2004), W96–W99.
8. Comeau, S.R., Gatchell, D.W., Vajda, S., Camacho, C.J., ClusPro: an automated docking and discrimination method for the prediction of protein complexes. Bioinformatics 20 (2004), 45–50.
9. DeLano, W.L., The PyMOL Molecular Graphics System. 2002, DeLano Scientific, San Carlos, CA, USA.
10. Etchison, D., Milburn, S.C., Edery, I., Sonenberg, N., Hershey, J.W., Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex. J. Biol. Chem. 257 (1982), 14806–14810.
11. Falah, N., Montserret, R., Lelogeais, V., Schuffenecker, I., Lina, B., Cortay, J.C., Violot, S., Blocking human enterovirus 71 replication by targeting viral 2A protease. J. Antimicrob. Chemother. 67 (2012), 2865–2869.
12. Foeger, N., Schmid, E.M., Skern, T., Human rhinovirus 2 2Apro recognition of eukaryotic initiation factor 4GI. Involvement of an exosite. J. Biol. Chem., 278, 2003 (33200-32007).
13. Gradi, A., Imataka, H., Svitkin, Y.V., Rom, E., Raught, B., Morino, S., Sonenberg, N., A novel functional human eukaryotic translation initiation factor 4G. Mol. Cell. Biol. 18 (1998), 334–342.
14. Gradi, A., Svitkin, Y.V., Imataka, H., Sonenberg, N., Proteolysis of human eukaryotic translation initiation factor eIF4GII, but not eIF4GI, coincides with the shutoff of host protein synthesis after poliovirus infection. Proc. Natl. Acad. Sci. USA 95 (1998), 11089–11094.
15. Gradi, A., Svitkin, Y.V., Sommergruber, W., Imataka, H., Morino, S., Skern, T., Sonenberg, N., Human rhinovirus 2A proteinase cleavage sites in eukaryotic initiation factors (eIF) 4GI and eIF4GII are different. J. Virol. 77 (2003), 5026–5029.
16. Gruner, S., Peter, D., Weber, R., Wohlbold, L., Chung, M.Y., Weichenrieder, O., Valkov, E., Igreja, C., Izaurralde, E., The structures of eIF4E-eIF4G complexes reveal an extended interface to regulate translation initiation. Mol. Cell 64 (2016), 467–479.
17. Haghighat, A., Svitkin, Y., Novoa, I., Kuechler, E., Skern, T., Sonenberg, N., The eIF4G-eIF4E complex is the target for direct cleavage by the rhinovirus 2A proteinase. J. Virol. 70 (1996), 8444–8450.
18. Knowles, N.J., Hovi, T., Hyypiä, T., King, A.M.Q., Lindberg, A.M., Pallansch, M.A., Palmenberg, A.C., Simmonds, P., Skern, T., Stanway, G., Yamashita, T., Zell, R., Picornaviridae. King, A.M.Q., Adams, M.J., Carstens, E.B., Lefkowitz, E.J., (eds.) Virus Taxonomy: Classification and Nomenclature of Viruses: Ninth Report of the International Committee on Taxonomy of Viruses, 2012, Elsevier, San Diego, 855–880.
19. Kozakov, D., Beglov, D., Bohnuud, T., Mottarella, S.E., Xia, B., Hall, D.R., Vajda, S., How good is automated protein docking?. Proteins 81 (2013), 2159–2166.
20. Krissinel, E., Henrick, K., Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372 (2007), 774–797.
21. Lamphear, B.J., Yan, R., Yang, F., Waters, D., Liebig, H.D., Klump, H., Kuechler, E., Skern, T., Rhoads, R.E., Mapping the cleavage site in protein synthesis initiation factor eIF-4 gamma of the 2A proteases from human Coxsackievirus and rhinovirus. J. Biol. Chem. 268 (1993), 19200–19203.
22. Lee, W., Watters, K.E., Troupis, A.T., Reinen, N.M., Suchy, F.P., Moyer, K.L., Frederick, R.O., Tonelli, M., Aceti, D.J., Palmenberg, A.C., Markley, J.L., Solution structure of the 2A protease from a common cold agent, human rhinovirus C2, strain W12. PLoS One, 9, 2014, e97198.
23. Liebig, H.D., Ziegler, E., Yan, R., Hartmuth, K., Klump, H., Kowalski, H., Blaas, D., Sommergruber, W., Frasel, L., Lamphear, B., et al. Purification of two picornaviral 2A proteinases: interaction with eIF-4 gamma and influence on in vitro translation. Biochemistry 32 (1993), 7581–7588.
24. Mader, S., Lee, H., Pause, A., Sonenberg, N., The translation initiation factor eIF-4E binds to a common motif shared by the translation factor eIF-4 gamma and the translational repressors 4E-binding proteins. Mol. Cell. Biol. 15 (1995), 4990–4997.
25. Makela, M.J., Puhakka, T., Ruuskanen, O., Leinonen, M., Saikku, P., Kimpimaki, M., Blomqvist, S., Hyypia, T., Arstila, P., Viruses and bacteria in the etiology of the common cold. J. Clin. Microbiol. 36 (1998), 539–542.
26. Marcotrigiano, J., Gingras, A.C., Sonenberg, N., Burley, S.K., Cocrystal structure of the messenger RNA 5′ cap-binding protein (eIF4E) bound to 7-methyl-GDP. Cell 89 (1997), 951–961.
27. Martinez-Salas, E., Ryan, M.D., Translation and protein processing. Ehrenfeld, E., Domingo, E., Roos, R., (eds.) The Picornaviruses, 2010, ASM Press, 141–146.
28. Mu, Z., Wang, B., Zhang, X., Gao, X., Qin, B., Zhao, Z., Cui, S., Crystal structure of 2A proteinase from hand, foot and mouth disease virus. J. Mol. Biol. 425 (2013), 4530–4543.
29. Neubauer, D., Aumayr, M., Gosler, I., Skern, T., Specificity of human rhinovirus 2A(pro) is determined by combined spatial properties of four cleavage site residues. J. Gen. Virol. 94 (2013), 1535–1546.
30. Ohlmann, T., Pain, V.M., Wood, W., Rau, M., Morley, S.J., The proteolytic cleavage of eukaryotic initiation factor (eIF) 4G is prevented by eIF4E binding protein (PHAS-I; 4E-BP1) in the reticulocyte lysate. EMBO J. 16 (1997), 844–855.
31. Penman, S., Scherrer, K., Becker, Y., Darnell, J.E., Polyribosomes in normal and poliovirus-infected hela cells and their relationship to messenger-rna. Proc. Natl. Acad. Sci. USA 49 (1963), 654–662.
32. Peter, D., Igreja, C., Weber, R., Wohlbold, L., Weiler, C., Ebertsch, L., Weichenrieder, O., Izaurralde, E., Molecular architecture of 4E-BP translational inhibitors bound to eIF4E. Mol. Cell 57 (2015), 1074–1087.
33. Petersen, J.F., Cherney, M.M., Liebig, H.D., Skern, T., Kuechler, E., James, M.N., The structure of the 2A proteinase from a common cold virus: a proteinase responsible for the shut-off of host-cell protein synthesis. EMBO J. 18 (1999), 5463–5475.
34. Reed, L.J., Muench, H., A simple method of estimating 50% end-points. Am. J. Hyg. 27 (1938), 493–497.
35. Schmid, E., Strukturspezifische Untersuchung rhinoviraler Proteasen unter besonderer Berücksichtigung der Spaltung der eIF4G Isoformen. 2002, Instititute of Medical Biochemistry, University of Vienna, Vienna, 85.
36. Seipelt, J., Liebig, H.D., Sommergruber, W., Gerner, C., Kuechler, E., 2A proteinase of human rhinovirus cleaves cytokeratin 8 in infected HeLa cells. J. Biol. Chem. 275 (2000), 20084–20089.
37. Sommergruber, W., Ahorn, H., Zophel, A., Maurer-Fogy, I., Fessl, F., Schnorrenberg, G., Liebig, H.D., Blaas, D., Kuechler, E., Skern, T., Cleavage specificity on synthetic peptide substrates of human rhinovirus 2 proteinase 2A. J. Biol. Chem. 267 (1992), 22639–22644.
38. Sommergruber, W., Seipelt, J., Fessl, F., Skern, T., Liebig, H.D., Casari, G., Mutational analyses support a model for the HRV2 2A proteinase. Virology 234 (1997), 203–214.
39. Sousa, C., Schmid, E.M., Skern, T., Defining residues involved in human rhinovirus 2A proteinase substrate recognition. FEBS Lett. 580 (2006), 5713–5717.
40. Steinberger, J., Grishkovskaya, I., Cencic, R., Juliano, L., Juliano, M.A., Skern, T., Foot-and-mouth disease virus leader proteinase: structural insights into the mechanism of intermolecular cleavage. Virology 468–470C (2014), 397–408.
41. Svitkin, Y.V., Gradi, A., Imataka, H., Morino, S., Sonenberg, N., Eukaryotic initiation factor 4GII (eIF4GII), but not eIF4GI, cleavage correlates with inhibition of host cell protein synthesis after human rhinovirus infection. J. Virol. 73 (1999), 3467–3472.
42. Tapparel, C., Junier, T., Gerlach, D., Cordey, S., Van Belle, S., Perrin, L., Zdobnov, E.M., Kaiser, L., New complete genome sequences of human rhinoviruses shed light on their phylogeny and genomic features. BMC Genom., 8, 2007, 224.
43. Velankar, S., Alhroub, Y., Best, C., Caboche, S., Conroy, M.J., Dana, J.M., Fernandez Montecelo, M.A., van Ginkel, G., Golovin, A., Gore, S.P., Gutmanas, A., Haslam, P., Hendrickx, P.M., Heuson, E., Hirshberg, M., John, M., Lagerstedt, I., Mir, S., Newman, L.E., Oldfield, T.J., Patwardhan, A., Rinaldi, L., Sahni, G., Sanz-Garcia, E., Sen, S., Slowley, R., Suarez-Uruena, A., Swaminathan, G.J., Symmons, M.F., Vranken, W.F., Wainwright, M., Kleywegt, G.J., PDBe: protein data bank in Europe. Nucleic Acids Res. 40 (2012), D445–D452.
44. Ventoso, I., MacMillan, S.E., Hershey, J.W., Carrasco, L., Poliovirus 2A proteinase cleaves directly the eIF-4G subunit of eIF-4F complex. FEBS Lett. 435 (1998), 79–83.
45. Wang, Q.M., Johnson, R.B., Sommergruber, W., Shepherd, T.A., Development of in vitro peptide substrates for human rhinovirus-14 2A protease. Arch. Biochem. Biophys. 356 (1998), 12–18.
46. Watters, K., Palmenberg, A.C., Differential processing of nuclear pore complex proteins by rhinovirus 2A proteases from different species and serotypes. J. Virol. 85 (2011), 10874–10883.
47. Whitton, J.L., Cornell, C.T., Feuer, R., Host and virus determinants of picornavirus pathogenesis and tropism. Nat. Rev. Microbiol. 3 (2005), 765–776.
48. Yu, S.F., Lloyd, R.E., Characterization of the roles of conserved cysteine and histidine residues in poliovirus 2A protease. Virology 186 (1992), 725–735.